Morgan Stanley (NYSE:MS) Institutional Investors Sentiment Improved in Q4 2017

April 25, 2018 - By Louis Casey

Morgan Stanley (NYSE:MS) Logo

Sentiment for Morgan Stanley (NYSE:MS)

Morgan Stanley (NYSE:MS) institutional sentiment increased to 1.1 in 2017 Q4. Its up 0.16, from 0.94 in 2017Q3. The ratio increased, as 366 hedge funds increased and started new stock positions, while 333 sold and decreased positions in Morgan Stanley. The hedge funds in our partner’s database now have: 1.51 billion shares, down from 1.53 billion shares in 2017Q3. Also, the number of hedge funds holding Morgan Stanley in their top 10 stock positions was flat from 26 to 26 for the same number . Sold All: 38 Reduced: 295 Increased: 255 New Position: 111.

Morgan Stanley, a financial holding company, provides various financial services and products to firms, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company has market cap of $92.80 billion. The companyÂ’s Institutional Securities segment offers capital raising and financial advisory services, including services related to the underwriting of debt, equity, and other securities, as well as advice on mergers and acquisitions, restructurings, real estate, and project finance. It has a 17.04 P/E ratio. This segment also provides sales and trading services, such as sales, financing, and market-making services in equity securities and fixed income products, including foreign exchange and commodities, as well as prime brokerage services; corporate loans, commercial and residential mortgage lending, and asset-backed lending; financing for equities and commodities customers; loans to municipalities; and investments and research services.

The stock decreased 1.43% or $0.76 during the last trading session, reaching $52.31. About 6.90 million shares traded. Morgan Stanley (NYSE:MS) has risen 27.83% since April 25, 2017 and is uptrending. It has outperformed by 16.28% the S&P500.

Mitsubishi Ufj Financial Group Inc holds 100% of its portfolio in Morgan Stanley for 432.02 million shares. Valueact Holdings L.P. owns 17.96 million shares or 9.53% of their US portfolio. Moreover, Dsam Partners (London) Ltd has 6.98% invested in the company for 791,331 shares. The United Kingdom-based Wellcome Trust Ltd (The) As Trustee Of The Wellcome Trust has invested 6.7% in the stock. Paragon Associates & Paragon Associates Ii Joint Venture, a Texas-based fund reported 142,500 shares.

Morgan Stanley (NYSE:MS) Ratings Coverage

Ratings analysis reveals 62% of Morgan Stanley’s analysts are positive. Out of 13 Wall Street analysts rating Morgan Stanley, 8 give it “Buy”, 1 “Sell” rating, while 4 recommend “Hold”. The lowest target is $51 while the high is $72.0. The stock’s average target of $60.14 is 14.97% above today’s ($52.31) share price. MS was included in 20 notes of analysts from December 13, 2017. The stock of Morgan Stanley (NYSE:MS) earned “Outperform” rating by Credit Suisse on Thursday, April 19. The stock of Morgan Stanley (NYSE:MS) earned “Buy” rating by Keefe Bruyette & Woods on Thursday, December 21. RBC Capital Markets maintained the stock with “Buy” rating in Friday, January 19 report. The company was maintained on Monday, April 9 by Sandler O’Neill. The stock of Morgan Stanley (NYSE:MS) earned “Buy” rating by BMO Capital Markets on Thursday, January 18. The stock of Morgan Stanley (NYSE:MS) has “Hold” rating given on Friday, January 19 by Sandler O’Neill. Atlantic Securities upgraded the stock to “Overweight” rating in Wednesday, January 10 report. The firm has “Equal-Weight” rating by Barclays Capital given on Thursday, April 19. As per Wednesday, December 13, the company rating was upgraded by Wood. Credit Suisse downgraded Morgan Stanley (NYSE:MS) rating on Thursday, January 18. Credit Suisse has “Hold” rating and $61.0 target.

Morgan Stanley (NYSE:MS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: